Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population

Weinblatt, ME, Fleischmann, R, van Vollenhoven, RF et al. (8 more authors) (2015) Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population. Arthritis Research and Therapy, 17. 325. ISSN 1478-6354

Abstract

Metadata

Authors/Creators:
  • Weinblatt, ME
  • Fleischmann, R
  • van Vollenhoven, RF
  • Emery, P
  • Huizinga, TWJ
  • Cutolo, M
  • van der Heijde, D
  • Duncan, B
  • Davies, O
  • Luijtens, K
  • Dougados, M
Copyright, Publisher and Additional Information: © 2015, Weinblatt et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Rheumatoid arthritis; Anti-TNF; DMARDs (biologic)
Dates:
  • Accepted: 29 October 2015
  • Published: 15 November 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 27 Jan 2016 10:41
Last Modified: 12 Feb 2019 12:57
Published Version: http://dx.doi.org/10.1186/s13075-015-0841-9
Status: Published
Publisher: BioMed Central
Identification Number: https://doi.org/10.1186/s13075-015-0841-9
Related URLs:

Export

Statistics